Table 1.
Baseline clinical characteristics of CHF patients
| All (n = 55) | Cardiac event (n = 13) | No cardiac event (n = 42) | p value | |
|---|---|---|---|---|
| Age (years) | 66.3 ± 8.0 | 66.4±7.0 | 66.2±8.4 | 0.118 |
| Male (%) | 43 (78) | 10 (77) | 33 (79) | 0.809 |
| Etiology heart failure | 0.79 | |||
| Ischemic (%) | 33 (60) | 8 (62) | 25 (60) | |
| Non-ischemic (%) | 22 (40) | 5 (38) | 17 (40) | |
| Blood pressure | ||||
| Systolic (mmHg) | 125 ± 17 | 126 ± 14 | 125 ± 19 | 0.223 |
| Diastolic (mmHg) | 76 ± 10 | 77±8 | 75±11 | 0.148 |
| LVEF (%) | 22.4 ± 6.3 | 23.9 ± 6.6 | 22.1 ± 6.2 | 0.491 |
| NYHA | 0.051 | |||
| Class II (%) | 41 (75) | 8 (62) | 33 (79) | |
| Class III (%) | 14 (25) | 5 (38) | 9 (21) | |
| Medication | ||||
| Betablockers (%) | 43 (78) | 9 (69) | 34 (81) | 0.118 |
| ACE-I/ARB s(%) | 50 (91) | 13 (100) | 37 (88) | 0.004 |
| MRAs (%) | 18 (33) | 5 (38) | 13 (31) | 0.560 |
| Loop diuretics (%) | 38 (69) | 10 (77) | 28 (67) | 0.122 |
| Statines (%) | 38 (69) | 9 (69) | 29 (69) | 0.980 |
| Aspirin (%) | 32 (58) | 6 (46) | 26 (62) | 0.448 |
| 123I-mIBG parameters | ||||
| Early H/M ratio | 2.12 ± 0.39 | 2.00 ± 0.28 | 2.16 ± 0.42 | 0.140 |
| Late H/M ratio | 1.84 ± 0.40 | 1.66 ± 0.28 | 1.90 ± 0.42 | 0.137 |
| 123I-mIBG WO | 13.0 ± 10.9 | 19.8 ± 10.6 | 11.8 ± 10.8 | 0.897 |